Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Nov;52(11):769–770. doi: 10.1136/ard.52.11.769

Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target?

T Cawston 1
PMCID: PMC1005185  PMID: 8250606

Full text

PDF
769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews H. J., Plumpton T. A., Harper G. P., Cawston T. E. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions. 1992 Sep;37(1-2):147–154. doi: 10.1007/BF01987904. [DOI] [PubMed] [Google Scholar]
  2. Brinckerhoff C. E. Joint destruction in arthritis: metalloproteinases in the spotlight. Arthritis Rheum. 1991 Sep;34(9):1073–1075. doi: 10.1002/art.1780340902. [DOI] [PubMed] [Google Scholar]
  3. Cawston T. E., Mercer E., de Silva M., Hazleman B. L. Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum. 1984 Mar;27(3):285–290. doi: 10.1002/art.1780270306. [DOI] [PubMed] [Google Scholar]
  4. Cawston T. E., Murphy G., Mercer E., Galloway W. A., Hazleman B. L., Reynolds J. J. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J. 1983 May 1;211(2):313–318. doi: 10.1042/bj2110313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clark I. M., Powell L. K., Ramsey S., Hazleman B. L., Cawston T. E. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993 Mar;36(3):372–379. doi: 10.1002/art.1780360313. [DOI] [PubMed] [Google Scholar]
  6. Gordon J. L., Drummond A. H., Galloway W. A. Metalloproteinase inhibitors as therapeutics. Clin Exp Rheumatol. 1993 Mar-Apr;11 (Suppl 8):S91–S94. [PubMed] [Google Scholar]
  7. Kushner I., Dawson N. V. Changing perspectives in the treatment of rheumatoid arthritis. J Rheumatol. 1992 Dec;19(12):1831–1834. [PubMed] [Google Scholar]
  8. Lloyd L. F., Skarzyński T., Wonacott A. J., Cawston T. E., Clark I. M., Mannix C. J., Harper G. P. Crystallization and preliminary X-ray analysis of porcine synovial collagenase. J Mol Biol. 1989 Nov 5;210(1):237–238. doi: 10.1016/0022-2836(89)90304-5. [DOI] [PubMed] [Google Scholar]
  9. Murphy G., Cawston T. E., Galloway W. A., Barnes M. J., Bunning R. A., Mercer E., Reynolds J. J., Burgeson R. E. Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J. 1981 Dec 1;199(3):807–811. doi: 10.1042/bj1990807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Page Thomas D. P., King B., Stephens T., Dingle J. T. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann Rheum Dis. 1991 Feb;50(2):75–80. doi: 10.1136/ard.50.2.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rifkin D. B., Tsuboi R., Mignatti P. The role of proteases in matrix breakdown during cellular invasion. Am Rev Respir Dis. 1989 Oct;140(4):1112–1113. doi: 10.1164/ajrccm/140.4.1112. [DOI] [PubMed] [Google Scholar]
  12. Tolley S., Murphy G., O'Shea M., Ward R., Docherty A., Cockett M., Rawas A., Davies G. Crystallization and preliminary X-ray analysis of a truncated tissue metalloproteinase inhibitor delta 128-194 TIMP-2. J Mol Biol. 1993 Feb 20;229(4):1163–1164. doi: 10.1006/jmbi.1993.1114. [DOI] [PubMed] [Google Scholar]
  13. Wentworth J. S., Paterson C. A., Gray R. D. Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn. Invest Ophthalmol Vis Sci. 1992 Jun;33(7):2174–2179. [PubMed] [Google Scholar]
  14. Ziff M. Rheumatoid arthritis--its present and future. J Rheumatol. 1990 Feb;17(2):127–133. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES